88IV - PR Newswire Asia's news


Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session CHENGDU, China , Sept. 22, 2026 /PRNewswire/ -- The 2026 European Society for Medical Oncology (ESMO) Congress will be held in Madrid, Spain, from October 23 to 27. Multiple Phase III clinical studies ... 2026-09-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset SUZHOU, China , Sept. 22, 2026 /PRNewswire/ -- Boomray Pharmaceuticals Co., Ltd. ("BoomRay"), a clinical-stage biotechnology company pioneering innovative radioligand therapies (RLTs) for precision ... 2026-09-22T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Bestzyme Launches World's First Dedicated, Automated Smart Production Line for Sweet Proteins in Jinan JINAN, China , Sept. 22, 2026 /PRNewswire/ -- Bestzyme, a synthetic biology company under GenScript Biotech, today announced the completion of the world's first dedicated, automated smart production ... 2026-09-22T Agriculture Biotechnology Chemical Food/Beverages
Ivonescimab First-Line Biliary Tract Cancer Phase III Overall Survival Data Selected as ESMO Late-Breaking Abstract; Nearly 30 Akeso Studies to Be Presented at ESMO 2026 HONG KONG , Sept. 22, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that nearly 30 clinical studies of its globally first-in-class bispecific antibodies ... 2026-09-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
The Next Chapter of B7-H3: From Systemic Disease to the Brain Early Data for T-MAXIMUM's B7-H3 Allogeneic CAR-T in Brain Metastases Presented at WCLC 2026 ... 2026-09-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi XDC Celebrates GMP Release of Singapore Site, Ushering in a New Era of Global Expansion SINGAPORE , Sept. 21, 2026 /PRNewswire/ --WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused ... 2026-09-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Clean Bio Korea to Showcase Indonesia-Validated Air-Fit at Hospital Expo 2026 SEOUL, South Korea , Sept. 21, 2026 /PRNewswire/ -- Clean Bio Co., Ltd, a Korean indoor air quality solutions company, will showcase Air-Fit, its air purification, sterilization and deodorization solution, ... 2026-09-21T Biotechnology Health Care/Hospital Infectious Disease Control
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global ... 2026-09-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Announces First Patient Dosed in Pivotal Phase III CLINCH-3 Study of ATG-022 SHANGHAI and HONG KONG , Sept. 21, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-09-21T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia SINGAPORE , Sept. 21, 2026 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) today announced an expansion of its existing partnership with Incyte Biosciences International, ... 2026-09-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology